We are live on ! Find out more
OCA

OpenArc Corporate Advisory Portfolio holdings

AUM $8.41B
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
Cap. Flow
+$539M
Cap. Flow %
6.42%
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Avg Time Held
1.6 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.7 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.82%
2 Technology 16.24%
3 Consumer Discretionary 5.63%
4 Healthcare 3.98%
5 Industrials 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LNG icon
476
Cheniere Energy
LNG
$58.3B
$517K 0.01%
2,163
-670
-24% -$167K
2026 Q1
1 quarter
GSK icon
477
GSK
GSK
$94B
$510K 0.01%
9,728
+175
+2% +$9.26K
2025 Q4
2 quarters
AUR icon
478
Aurora
AUR
$11.3B
$508K 0.01%
74,414
+21,534
+41% +$132K
2025 Q4
2 quarters
GDX icon
479
VanEck Gold Miners ETF
GDX
$26.6B
$507K 0.01%
6,720
– –
2025 Q4
2 quarters
ENB icon
480
Enbridge
ENB
$105B
$506K 0.01%
9,331
+1,090
+13% +$59.8K
2025 Q4
2 quarters
CBRE icon
481
CBRE Group
CBRE
$37.9B
$505K 0.01%
3,753
+130
+4% +$17.9K
2025 Q4
2 quarters
SMIG icon
482
Bahl & Gaynor Small/Mid Cap Income Growth ETF
SMIG
$1.44B
$503K 0.01%
15,321
– –
2026 Q1
1 quarter
BLCR icon
483
BlackRock Large Cap Core ETF
BLCR
$9.71B
$499K 0.01%
9,902
-390
-4% -$18.8K
2026 Q1
1 quarter
ET icon
484
Energy Transfer Partners
ET
$70.3B
$497K 0.01%
26,007
+4,553
+21% +$88.2K
2025 Q4
2 quarters
SCHV icon
485
Schwab US Large-Cap Value ETF
SCHV
$15.4B
$497K 0.01%
14,269
-278
-2% -$9.16K
2025 Q4
2 quarters
AME icon
486
Ametek
AME
$57.3B
$497K 0.01%
2,053
-78
-4% -$18K
2025 Q4
2 quarters
NUE icon
487
Nucor
NUE
$57.1B
$494K 0.01%
+2,219
New +$502K
2026 Q2
0 quarters
PFFD icon
488
Global X US Preferred ETF
PFFD
$2B
$493K 0.01%
26,351
-82
-0.3% -$1.55K
2026 Q1
1 quarter
ACWX icon
489
iShares MSCI ACWI ex US ETF
ACWX
$17.6B
$492K 0.01%
6,466
-38
-0.6% -$2.83K
2025 Q4
2 quarters
MFG icon
490
Mizuho Financial
MFG
$128B
$488K 0.01%
50,977
+10,497
+26% +$94.3K
2025 Q4
2 quarters
EZU icon
491
iShare MSCI Eurozone ETF
EZU
$9.21B
$484K 0.01%
6,970
-679
-9% -$45.8K
2025 Q4
2 quarters
CART icon
492
Maplebear
CART
$11.4B
$483K 0.01%
+10,207
New +$427K
2026 Q2
0 quarters
ENTG icon
493
Entegris
ENTG
$24.4B
$483K 0.01%
2,687
-126
-4% -$18.2K
2025 Q4
2 quarters
CMCSA icon
494
Comcast
CMCSA
$73.4B
$483K 0.01%
19,674
-5,159
-21% -$133K
2025 Q4
2 quarters
PBYI icon
495
Puma Biotechnology
PBYI
$531M
$482K 0.01%
59,491
-30,000
-34% -$220K
2025 Q4
2 quarters
BR icon
496
Broadridge
BR
$18.8B
$482K 0.01%
3,516
+2,096
+148% +$317K
2026 Q1
1 quarter
FTNT icon
497
Fortinet
FTNT
$142B
$480K 0.01%
3,126
+567
+22% +$65.5K
2025 Q4
2 quarters
CGGO icon
498
Capital Group Global Growth Equity ETF
CGGO
$12B
$480K 0.01%
11,336
+4,222
+59% +$164K
2025 Q4
2 quarters
APD icon
499
Air Products & Chemicals
APD
$63.2B
$478K 0.01%
1,630
-79
-5% -$23K
2025 Q4
2 quarters
TTE icon
500
TotalEnergies
TTE
$195B
$477K 0.01%
6,138
+797
+15% +$70.5K
2025 Q4
2 quarters

Similar funds

OpenArc Corporate Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.

  • OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
  • OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
  • OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
  • OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
  • OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
  • OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
  • OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.